Quantapore has announced that Feng Deng has joined the firm's board of directors in connection with the its latest financing round. Deng is the founder of Northern Light Venture Capital.
MiR Scientific (formerly miR Diagnostics) has appointed Laurence Klotz as chief medical officer. Klotz currently serves as chairman of the World Urologic Oncology Federation. He has also been a member of the Institute of Medical Science and a graduate faculty member at the University of Toronto since 2005, as well as a professor of surgery at the University of Toronto since 2000.
NanoView Biosciences has appointed Jerry Williamson as CEO. Williamson succeeds David Freedman, who will remain with the firm as chief operating officer. Williamson has 30 years of experience in commercial operations, business development, and corporate management in the life science industry. He previously served as president and CEO of KEW, and as CEO and president of Metamark Genetics.
For more recent items on executive appointments and promotions in the omics and molecular diagnostics industries, please see the People in the News page on our website.